Medical

NLCTA staff helped undergraduates from Harvey Mudd College use the facility’s electron beam to test a detector they designed. 

Researchers with the Doudna group used SSRL to uncover how viruses use special enzymes to evade a host's defenses. 

X-rays unveil new molecular structure details that will help researchers design novel drug therapies to address antibiotic resistant bacteria.

His visit highlighted the breadth of our world-class research and the people and collaborations that make it possible. A key theme of the day: how SLAC and the National Labs are advancing AI to accelerate discovery.

Oxidizing chemicals break this cellular power plant into useless bits, leading to  Parkinson’s disease, ALS, heart disease, diabetes, cancer and more. A small molecule could block the process.

The new findings highlight the need for ongoing monitoring of H5N1’s evolution in nature. 

Researchers found a protein that's essential for an enterovirus to enter human cells. That could help the search for vaccines and treatments. 

The results, which show how the protein adds nucleotides to the growing RNA chain, could lead to more effective medications.

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs for the autoimmune disorder.

The method could lead to the development of new materials with tailored properties, with potential applications in fields such as climate change, quantum computing and drug design.

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.